Positron Corporation (POSC)
OTCMKTS · Delayed Price · Currency is USD
1.680
+0.080 (5.00%)
Aug 8, 2025, 10:15 AM EDT
Positron Market Cap
Positron has a market cap or net worth of $51.47 million as of August 8, 2025. Its market cap has increased by 65.42% in one year.
Market Cap
51.47M
Enterprise Value
n/a
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.68
Market Cap Chart
Since December 3, 1993, Positron's market cap has increased from 22.73M to 51.47M, an increase of 126.45%. That is a compound annual growth rate of 2.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 52.13M | 89.04% |
| Dec 30, 2024 | 27.58M | -29.54% |
| Dec 29, 2023 | 39.14M | 88.62% |
| Dec 29, 2022 | 20.75M | -34.40% |
| Dec 31, 2021 | 31.63M | 1,169.21% |
| Dec 31, 2020 | 2.49M | 42.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.57M |
| Glass House Brands | 474.59M |
| Spruce Biosciences | 427.59M |
| Northwest Biotherapeutics | 368.08M |
| CytoDyn | 337.23M |